新的无线EEG头盔可靠地测量临床试验中的大脑变化,加速了脑疾病药物开发。 A new wireless EEG headset reliably measures brain changes in clinical trials, speeding up drug development for brain disorders.

Cumulus Neuroscience在《科学报告》中发表了研究报告,其中显示无线干电磁头盔和短视测试可可靠地测量临床试验地点的神经可塑性。 Cumulus Neuroscience has published research in Scientific Reports showing a wireless dry-EEG headset with a brief visual test can reliably measure neuroplasticity across clinical trial sites. 该方法使用NeuLogiq平台和波盘分析方法,检测出持续的脑活动变化-P1振幅增加,N1b振幅减少-与既定的可靠性匹配进行测试测试。 The method, using the NeuLogiq® Platform and wavelet-based analysis, detected consistent brain activity changes—increased P1 amplitude, decreased N1b amplitude—with test-retest reliability matching established standards. 它为监测早期抑郁症、阿尔茨海默氏症和中风恢复试验中的大脑变化提供了一种可扩展的、非侵入性的方式,有可能加速CNS药物开发。 It offers a scalable, non-invasive way to monitor brain changes in early-phase trials for depression, Alzheimer’s, and stroke recovery, potentially speeding up CNS drug development.